https://www.drugtargetreview.com/news/107920/sars-cov-2-antibodies-can-bind-to-two-viral-targets-at-once/
0
0
1/19/23 at 1:47pm
Organization
Drug Target Review
32 words
0
Comments
US researchers find that SARS-CoV-2 bivalent antibodies can continue to neutralise Omicron and Omicron lineages.
You are the first to view
Create an account
or login to join the discussion